Search filters

List of works by Jérôme Fayette

Antiangiogenic effects in patients with progressive desmoplastic small round cell tumor: data from the French national registry dedicated to the use of off-labeled targeted therapy in sarcoma (OUTC's)

scientific article

Autocrine role for Gas6 with Tyro3 and Axl in leiomyosarcomas

scientific article published on 25 January 2013

Bevacizumab and paclitaxel for breast cancer patients with central nervous system metastases: a case series.

scientific article published in May 2009

Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis

scientific article

ET-743: a novel agent with activity in soft tissue sarcomas

scientific article

ET-743: a novel agent with activity in soft-tissue sarcomas

scientific article

Efficacy of trabectedin for advanced sarcomas in clinical trials versus compassionate use programs: analysis of 92 patients treated in a single institution

scientific article published in January 2010

Emerging drugs for the treatment of soft tissue sarcomas

scientific article published on March 2007

Erratum

First results of the EORTC-SPECTA/Arcagen study exploring the genomics of rare cancers in collaboration with the European reference network EURACAN

scientific article published on 01 December 2020

Imatinib and solid tumours

scientific article published in January 2008

Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial

scientific article

News of the year 2005 in sarcomas

scientific article published in January 2006

Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057).

scientific article published on 12 October 2017

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

scientific article (publication date: 22 October 2015)

Phase III trial of standard versus dose-intensified doxorubicin, ifosfamide and dacarbazine (MAID) in the first-line treatment of metastatic and locally advanced soft tissue sarcoma

scientific article

Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group

scientific article

The sum of gains and losses of genes encoding the protein tyrosine kinase targets predicts response to multi-kinase inhibitor treatment: Characterization, validation, and prognostic value

scientific article

[Neoadjuvant chemotherapy in sarcoma]

scientific article published on 01 November 2006

[Prognostic factors for febrile neutropenia].

scientific article

Paulina is supported by:

About Paulina

Help